DNTH · Dianthus Therapeutics, Inc. /DE/

NasdaqHealthcareBiotechnology

Dianthus Therapeutics Inc. Is A Clinical-Stage Biotechnology Company Dedicated To Developing Potentially Best-In-Class Therapies For Patients With Severe Autoimmune Diseases. The Company Operates As A Single Segment And Has One Reportable Segment, Focusing On Creating Next-Generation Treatments To Revolutionize The Management Of Severe Autoimmune Conditions. The Team Comprises Experienced Biotech And Pharma Executives. The Pipeline Includes The Potential Of Claseprubart, A Next-Generation Complement Therapeutic.

HealthcareNasdaqUSMid Float

FLOAT

48.8M

FREE FLOAT %

89%

SHARES O/S

54.8M

MARKET CAP

$4.29B

EXCHANGE

Nasdaq

COUNTRY

DNTH Catalyst History

No catalysts recorded for DNTH yet

Day Trader Sniper hasn't classified a publishable catalyst for DNTH yet. New events appear here as they're scored.

Be early on the next DNTH spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

DNTH · Dianthus Therapeutics, Inc. /DE/

DNTH Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.